Compare TOWN & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOWN | PTGX |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | 2976 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 6.4B |
| IPO Year | N/A | 2016 |
| Metric | TOWN | PTGX |
|---|---|---|
| Price | $34.14 | $97.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $108.23 |
| AVG Volume (30 Days) | ★ 494.4K | 462.9K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.09% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | N/A |
| Revenue This Year | $35.63 | $874.25 |
| Revenue Next Year | $5.18 | N/A |
| P/E Ratio | ★ $16.23 | $2,055.80 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.91 | $49.86 |
| 52 Week High | $37.86 | $107.84 |
| Indicator | TOWN | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 49.45 | 47.17 |
| Support Level | $32.03 | $96.36 |
| Resistance Level | $35.01 | $104.85 |
| Average True Range (ATR) | 0.63 | 4.25 |
| MACD | -0.02 | -0.26 |
| Stochastic Oscillator | 59.42 | 42.59 |
Towne Bank is a financial services company serving individuals, commercial enterprises and professionals, offering retail and commercial banking services in Virginia and North Carolina. The company has four reportable segments: Banking, which provides loan and deposit services, commercial mortgage brokerage, and investment and asset management services; Mortgage, which originates mortgage loans principally sold in the secondary market through purchase commitments from investors; Resort Vacation Management, which provides residential resort property management services; and Insurance, which provides property, casualty, life and health insurance solutions for businesses, individuals and community organizations through a variety of carriers.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.